<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ymj</journal-id><journal-title-group><journal-title xml:lang="ru">Якутский медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Yakut Medical Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1813-1905</issn><issn pub-type="epub">2312-1017</issn><publisher><publisher-name>ЯНЦ КМП</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25789/YMJ.2023.83.19</article-id><article-id custom-type="elpub" pub-id-type="custom">ymj-266</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АКТУАЛЬНАЯ ТЕМА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ACTUAL TOPIC</subject></subj-group></article-categories><title-group><article-title>Интегральный показатель оценки окислительного стресса в крови новорождённых от ВИЧ-инфицированных матерей</article-title><trans-title-group xml:lang="en"><trans-title>Blood integrated indicator of oxidative stress in infants born to HIV-infected mothers</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8591-8619</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Курашова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kurashova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>КУРАШОВА Надежда Александровна – д.б.н., в.н.с.</p><p>Иркутск</p></bio><bio xml:lang="en"><p>KURASHOVA Nadezhda A. – Dr. Sci. (Biology), leading researcher, Laboratory of Pathophysiology</p><p>Irkutsk</p></bio><email xlink:type="simple">nakurashova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7965-8061</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петрова</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrova</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ПЕТРОВА Алла Германовна – д.м.н., проф., гл.н.с.</p><p>Иркутск</p></bio><bio xml:lang="en"><p>PETROVA Alla G. – Dr. Sci. (Med.), Professor, chief researcher, Laboratory of Infectology and Immune Prophylaxis in Pediatrics</p><p>Irkutsk</p></bio><email xlink:type="simple">rudial75@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8434-1600</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ваняркина</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Vanyarkina</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ВАНЯРКИНА Анастасия Сергеевна – к.м.н., в.н.с.</p><p>Иркутск</p></bio><bio xml:lang="en"><p>VANYARKINA Anastasia S. – Cand. Sci. (Med.), chief researcher, Laboratory of Infectology and Immune Prophylaxis in Pediatrics</p><p>Irkutsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0117-2563</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рычкова</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Rychkova</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>РЫЧКОВА Любовь Владимировна – д.м.н., член-корр. РАН, директор</p><p>Иркутск</p></bio><bio xml:lang="en"><p>RYCHKOVA Lubov V. – Dr. Sci. (Med.), Professor, Corresponding member of the Russian Academy of Sciences</p><p>Irkutsk</p></bio><email xlink:type="simple">iphr@sbamsr.irk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3255-2013</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Даренская</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Darenskaya</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ДАРЕНСКАЯ Марина Александровна – д.б.н., гл.н.с.</p><p>Иркутск</p></bio><bio xml:lang="en"><p>DARENSKAYA Marina A. – Dr. Sci. (Biology), chief researcher, Laboratory of Pathophysiology</p><p>Irkutsk</p></bio><email xlink:type="simple">marina_darenskaya@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Москалева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Moskaleva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>МОСКАЛЕВА Екатерина Владимировна – к.м.н., н.с.</p><p>Иркутск</p></bio><bio xml:lang="en"><p>MOSKALEVA Ekaterina V. – Cand. Sci. (Med.), Researcher, Laboratory of Infectology and Immune Prophylaxis in Pediatric</p><p>Irkutsk</p></bio><email xlink:type="simple">mkatena@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3354-2992</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колесникова</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolesnikova</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>КОЛЕСНИКОВА Любовь Ильинична – д.м.н., проф., акад. РАН, науч. руковод.</p><p>Иркутск</p></bio><bio xml:lang="en"><p>KOLESNIKOVA Lubov I. – Dr. Sci. (Med.), Professor, Member of the Russian Academy of Sciences, Academic Director</p><p>Irkutsk</p></bio><email xlink:type="simple">iphr@sbamsr.irk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Научный центр проблем здоровья семьи и репродукции человека»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Scientific Сentre for Family Health and Human Reproduction Problems</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2023</year></pub-date><pub-date pub-type="epub"><day>06</day><month>02</month><year>2025</year></pub-date><volume>0</volume><issue>3</issue><fpage>75</fpage><lpage>78</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Курашова Н.А., Петрова А.Г., Ваняркина А.С., Рычкова Л.В., Даренская М.А., Москалева Е.В., Колесникова Л.И., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Курашова Н.А., Петрова А.Г., Ваняркина А.С., Рычкова Л.В., Даренская М.А., Москалева Е.В., Колесникова Л.И.</copyright-holder><copyright-holder xml:lang="en">Kurashova N.A., Petrova A.G., Vanyarkina A.S., Rychkova L.V., Darenskaya M.A., Moskaleva E.V., Kolesnikova L.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://ymj.elpub.ru/jour/article/view/266">https://ymj.elpub.ru/jour/article/view/266</self-uri><abstract><p>Проведена индивидуальная оценка коэффициента окислительного стресса (КОС) у новорожденных от ВИЧ-инфицированных матерей путем определения содержания в крови субстратов окисления процессов липопероксидации с сопряженными двойными связями (Дв Св), диеновых конъюгатов, кетодиенов и сопряженных триенов, ТБК-активных продуктов, ретинола, α-токоферола, восстановленного и окисленного глутатиона, активности супероксиддисмутазы. Установлено, что коэффициент окислительного стресса в группе ВИЧ-экспонированных неинфицированных новорожденных статистически значимо выше по сравнению со здоровыми новорождёнными. Представленное значение коэффициента окислительного стресса свидетельствует о значительном дисбалансе в системе ПОЛ-АОЗ в сторону усиления процессов перекисного окисления липидов. Изменение концентрации субстратов и продуктов пероксидации в сторону увеличения приводит к деструкции липидов, а следовательно, к деградации мембранного комплекса клеток. Результаты проведенного исследования указывают на необходимость изучения группы перинатально ВИЧ-экспонированных неинфицированных новорожденных с целью определения прогностически значимых факторов развития патологических процессов как в раннем неонатальном периоде, так и в более поздних сроках развития младенцев.</p></abstract><trans-abstract xml:lang="en"><p>A single-center cross-sectional study was conducted from March 2020 to January 2021 and included 142 neonates born with a gestational age of more than 37 0/7 weeks. The aim of the work was an individual assessment of the oxidative stress index (OSI) in newborns of HIV-infected mothers. Materials and methods: the state of the LPO–AOD system was assessed by determining the content of lipid peroxidation oxidation substrates with conjugated double bonds (DB), diene conjugates (DC), ketodienes and conjugated trienes (KD and CT), TBA-active products in the blood (TBA-AP), retinol, α-tocopherol, reduced (GSH) and oxidized glutathione (GSSG), superoxide dismutase (SOD) activity. OSI was used to evaluate diﬀerences in lipid peroxidation processes in HIV-exposed uninfected newborns. Results: The index of oxidative stress in the group of HIV-exposed uninfected newborns was detected 1.98 times higher compared to healthy newborns and was 2.5 and 1.26, respectively. The value of the oxidative stress coeﬃcient indicates a signiﬁcant imbalance in the LPO-AOP system reﬂecting the enhancement of the lipid peroxidation processes. An increase in the concentration of substrates and products of peroxidation leads to the destruction of lipids, and, consequently, to the degradation of the cell membrane complex. Conclusion: The integral oxidative stress index is recommended as a general indicator that characterizes the level of lipid peroxidation products and antioxidant protection factors in a particular group. Also, OSI is more sensitive indicator than separated components of the system, which objectively represents the LPO–AOD system malfunctioning, and provides the comprehensive view to the both lipid peroxidation processes and the level (eﬀectiveness) of protective factors. To summarize, the results of the study point to the need to further investigations aimed to determination of prognostically signiﬁcant markers in PVEN, which could be involved or could indicate the pathological processes both in the early neonatal period and in the later stages of infant development.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>новорождённые</kwd><kwd>ВИЧ-инфицированные беременные</kwd><kwd>ВИЧ-инфекция</kwd><kwd>окислительный стресс</kwd><kwd>интегральный показатель</kwd></kwd-group><kwd-group xml:lang="en"><kwd>newborns</kwd><kwd>HIV-infected pregnant women</kwd><kwd>HIV infection</kwd><kwd>oxidative stress</kwd><kwd>integral index</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">ВИЧ и фертильность: нейроэндокринные и метаболические аспекты / О.Я. Лещенко, Е.В. Генич, М.А Даренская. [и др.] // ВИЧ-инфекция и иммуносупрессии. 2020; 12(4): 73-80. doi: 10.22328/2077-9828-2020-12-4-73-80</mixed-citation><mixed-citation xml:lang="en">HIV and infertility: neuro-endocrine and metabolic aspects / Leshchenko O.Ya., Genich E.V. [et al.] // HIV infection and immunosuppression. 2020;12(4): 73-80. doi: 10.22328/2077-9828-2020-12-4-73-80</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">ВИЧ и беременность: реалии XXI века / М.А. Рашидова, Л.Ф. Шолохов, А.Ю. Марянян [и др.] // Сибирский научный медицинский журнал. 2022; 42(2): 10-17. doi 10.18699/SSMJ20220202.</mixed-citation><mixed-citation xml:lang="en">HIV and pregnancy: realities of XXI century / Rashidova M.A., Sholokhov L.F., Marianian A.Yu. [et al] // Siberian Scientiﬁc Medical Journal. 2022; 42(2): 10-17. doi 10.18699/SSMJ20220202.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Воронин Е.Е., Латышева И.Б. ВИЧ-инфекция у беременных женщин и детей в Российской Федерации. Материалы конференции «Актуальные вопросы ВИЧ-инфекции. Охрана здоровья матери и ребёнка». СПб.: Человек и его здоровье; 2022: 3–5.</mixed-citation><mixed-citation xml:lang="en">Voronin E.E., Latysheva I.B. HIV infection in pregnant women and children in the Russian Federation. Materials of the conference “Topical issues of HIV infection. Maternal and child health." SPb.: Man and his health; 2022: 3–5.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Длина теломер лейкоцитов у новорождённых от ВИЧ-инфицированных матерей / Н.А. Курашова, А.С. Ваняркина, А.Г. Петрова [и др.] // Бюллетень экспериментальной биологии и медицины. 2023; 175(2): 227-232. doi: 10.47056/0365-9615-2023-175-2-227-232.</mixed-citation><mixed-citation xml:lang="en">Length of leukocyte telomeres in newborn from HIV-infected mothers. Kurashova N.A., Vanyarkina A.S., Petrova A.G. [et al] // Bulletin of Experimental Biology and Medicine. 2023; 175(2): 227-232. doi: 10.47056/0365-9615-2023-175-2-227-232.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Оценка про- и антиоксидантного статуса у женщин с ВИЧ и коинфекцией / Л.И. Колесникова, С.И. Колесников, М.А. Даренская [и др.] // Терапевтический архив. 2016; 88(11): 17–21. 10.17116/terarkh2016881117-21</mixed-citation><mixed-citation xml:lang="en">Evaluation of the pro- and antioxidant status of women with HIV or coinfection / Kolesnikova L.I., Kolesnikov S.I., Darenskaya M.A. [et al.] // Therapeutic archive. 2016; 88(11): 17-21. doi: 10.17116/terarkh2016881117-21</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Оценка окислительного стресса у женщин с нарушениями сна в постменопаузе с использованием интегрального показателя / Л.И. Колесникова, И.М. Мадаева, Н.В. Семенова [и др.] // Клиническая лабораторная диагностика. 2014; 59(12): 29-32.</mixed-citation><mixed-citation xml:lang="en">The evaluation of oxidative stress in women with sleep disturbances in post menopause conditions using integrated indicator / Kolesnikova L.I., Madaeva I.M., Semenova N.V. [et al] // Clinical laboratory diagnostics. 2014; 59(12): 29-32.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Оценка процессов перекисного окисления липидов и антиоксидантной защиты у мужчин с хронической монотрихомонадной инфекцией с помощью коэффициента окислительного стресса / Л.И. Колесникова, Л.А. Гребенкина, Н.А. Курашова [и др.] // Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук. 2011; 77(1): 74-76.</mixed-citation><mixed-citation xml:lang="en">Evaluation of processes of lipid peroxidation and antioxidant protection in men with chronic monotrichomonas infection by the factor of oxidative stress / Kolesnikova L.I., Grebenkina L.A., Kurashova N.A. [et al] // Bulletin of East Siberian Scientiﬁc center SB RAMS. 2011; 77(1): 74-76.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Применение интегрального показателя для оценки окислительного стресса у мужчин с патоспермией и сахарным диабетом 1 типа / Л.И. Колесникова, Н.А. Курашова, М.И. Долгих [и др.] // Урология. 2015; 4: 71-75.</mixed-citation><mixed-citation xml:lang="en">Application of integral indicator for assessment of oxidative stress in men with pathospermia and type 1 diabetes / Kolesnikova L.I., Kurashova N.A., Dolgih M.I. [et al] // Urology. 2015; 4: 71-75.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Association of maternal and infant inﬂammation with neurodevelopment in HIV-exposed uninfected children in a South African birth cohort / Sevenoaks T, Wedderburn CJ, Donald KA. [et al] // Brain Behav Immun. 2021; 91:65-73. doi: 10.1016/j.bbi.2020.08.021.</mixed-citation><mixed-citation xml:lang="en">Association of maternal and infant inﬂammation with neurodevelopment in HIV-exposed uninfected children in a South African birth cohort / Sevenoaks T, Wedderburn CJ, Donald KA. [et al] // Brain Behav Immun. 2021; 91:65-73. doi: 10.1016/j.bbi.2020.08.021.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Eﬀects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress / Ross AC, Leong T, Avery A. [et al] // HIV Med. 2012; 13: 98–106.</mixed-citation><mixed-citation xml:lang="en">Eﬀects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress / Ross AC, Leong T, Avery A. [et al] // HIV Med. 2012; 13: 98–106.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Features of the free radical oxidation process and antioxidant system in newborns born to HIV-infected of mothers who received antiretroviral therapies to prevent HIV transmission / Kurashova N.A., Vanyarkina A.S., Petrova A.G. [et al.] // Bulletin of Experimental Biology and Medicine. 2023; 174(4): 413-416. doi: 10.1007/s10517-023-05719-z</mixed-citation><mixed-citation xml:lang="en">Features of the free radical oxidation process and antioxidant system in newborns born to HIV-infected of mothers who received antiretroviral therapies to prevent HIV transmission / Kurashova N.A., Vanyarkina A.S., Petrova A.G. [et al.] // Bulletin of Experimental Biology and Medicine. 2023; 174(4): 413-416. doi: 10.1007/s10517-023-05719-z</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">NISDI LILAC Protocol. HIV-exposed-uninfected infants have increased inﬂammation and monocyte activation / Dirajlal-Fargo S, Mussi-Pinhata MM, Weinberg A. [et al] // AIDS. 2019; 33(5): 845-853. doi: 10.1097/QAD.0000000000002128.</mixed-citation><mixed-citation xml:lang="en">NISDI LILAC Protocol. HIV-exposed-uninfected infants have increased inﬂammation and monocyte activation / Dirajlal-Fargo S, Mussi-Pinhata MM, Weinberg A. [et al] // AIDS. 2019; 33(5): 845-853. doi: 10.1097/QAD.0000000000002128.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation / Zidar DA, Juchnowski S, Ferrari B. [et al] // J Acquir Immune Deﬁc Syndr. 2015; 69: 154–160.</mixed-citation><mixed-citation xml:lang="en">Oxidized LDL Levels Are Increased in HIV Infection and May Drive Monocyte Activation / Zidar DA, Juchnowski S, Ferrari B. [et al] // J Acquir Immune Deﬁc Syndr. 2015; 69: 154–160.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Prendergast AJ, Evans C. Children who are HIV-exposed and uninfected: evidence for action. AIDS. 2023; 37(2): 205-215. doi: 10.1097/QAD.0000000000003409.</mixed-citation><mixed-citation xml:lang="en">Prendergast AJ, Evans C. Children who are HIV-exposed and uninfected: evidence for action. AIDS. 2023; 37(2): 205-215. doi: 10.1097/QAD.0000000000003409.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
